ROMTech: Home-Based Tele-Rehabilitation
The patient started the program on day three. The session that mattered was the one they skipped in week five.
A category-level brief on home tele-rehab: the adherence gap it targets, the payer pathway that usually decides it, and where operations break.
What this is
A category-level context brief on home-based tele-rehabilitation for post-operative recovery: a guided rehab device plus remote monitoring in the patient's home, raising adherence and removing scheduling friction from in-clinic physical therapy.
This is a framework for the category, not company-specific analysis. No ROMTech device, protocol, or outcome data is described here.
Why the category has leverage
The problem is the adherence gap. Conventional PT loses patients to travel, to scheduling friction, and to simple drop-off.
Recovery quality drives function, patient satisfaction and downstream cost, so adherence gains have real leverage. Remote monitoring tightens the care pathway and removes the ambiguity about how a patient is actually progressing between visits.
What the evidence has to answer
- Range of motion, function scores, pain, time-to-milestones and readmissions — always with the follow-up question: versus what baseline?
- Does the product reduce clinician burden, or manufacture more follow-up work?
- Coverage status and episode-of-care economics, which frequently matter more to the outcome than clinical performance does.
Where it breaks
- Operations and logistics: onboarding, patient support, device delivery and returns. This is first-order, not back-office.
- Adoption requires both surgeon and PT buy-in, and either one can stall it.
- A crowded field of PT networks, digital rehab entrants and incumbents.
- The dominant failure mode is coverage friction combined with operational complexity — neither fatal alone, reliably fatal together.
Disclosure
GigHz holds a personal position or exposure in this company. That is disclosed here because you should weigh it.
Informational only. Not an offer to sell securities or a solicitation to buy, and not financial, medical, legal or tax advice. Past performance does not guarantee future results.
Informational only. Not investment, medical, legal, or tax advice. GigHz or its founder may hold a position in the company discussed — see the disclosure above.
Related from GigHz
Written and reviewed by Pouyan Golshani, MD, Interventional Radiologist — Last updated June 12, 2026
Part of the GigHz library: systems doctors were never taught.